Continuous administration of intravenous iron during haemodialysis.
A simple, safe and potentially cost effective method of giving intravenous iron to patients receiving regular haemodialysis therapy is described. The heparin and iron are mixed in normal saline and given as a continuous infusion via the syringe pump present on the modern dialysis machine. No pharmacological incompatibility was observed between iron polymaltose and Heparin Choay or Heparin Roche. No adverse reactions attributable to i.v. iron were observed in over 400 patients and more than 30,000 dialyses.
Granolleras
C
C
Department of Nephrology, University Hospital, Nîmes, France.
Zein
A
A
Oulès
R
R
Branger
B
B
Fourcade
J
J
Shaldon
S
S
D000707:Anaphylaxis / Q000517:prevention & control; D005290:Ferric Compounds / Q000008:administration & dosage / Q000009:adverse effects; D005293:Ferritins / Q000097:blood; D006493:Heparin / Q000008:administration & dosage; D006801:Humans; D007260:Infusion Pumps; D007262:Infusions, Intravenous; D007501:Iron / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood; D010314:Partial Thromboplastin Time; D006435:Renal Dialysis / Q000379:methods*; D012449:Safety; D014168:Transferrin / Q000378:metabolism
D005290:Ferric Compounds; D014168:Transferrin; D006493:Heparin; D005293:Ferritins; D007501:Iron; C013276:teferrol